Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest

Citations Over TimeTop 10% of 2006 papers

Abstract

The antiangiogenic agent fumagillin (Fg) and its analog TNP-470 bind to intracellular metalloprotease methionine aminopeptidase-2 (MetAP-2) and inhibit endothelial cell growth in a p53-dependent manner. To confirm the role of MetAP-2 in endothelial cell proliferation and to validate it as a physiological target for the Fg class of antiangiogenic agents, we have generated a conditional MetAP-2 knockout mouse. Ubiquitous deletion of the MetAP-2 gene (MAP2) resulted in an early gastrulation defect, which is bypassed in double MetAP-2/p53 knockout embryos. Targeted deletion of MAP2 specifically in the hemangioblast lineage resulted in abnormal vascular development, and these embryos die at the midsomite stage. In addition, knockdown of MetAP-2 using small interfering RNA or homologous recombination specifically suppresses the proliferation of cultured endothelial cells. Together, these results demonstrate an essential role for MetAP-2 in angiogenesis and indicate that MetAP-2 is responsible for the endothelial cell growth arrest induced by Fg and its derivatives.

Related Papers

• → Endothelial potential of human embryonic stem cells(2007)102 cited
• → Conditional Gene Knockout Using Cre Recombinase(2003)88 cited
• → Conditional Gene Knockout System in Cone Photoreceptors(2007)9 cited
• → Knockout mouse production assisted by <i>Blm</i> knockdown(2015)2 cited
• → Generation of Cre‐ loxP Mouse Models for Conditional Knockout and Overexpression of Genes in Various Heart Cells(2013)